Physiomics Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Peter Sargent

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	1.2yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	3.3yrs
Yönetim Kurulu ortalama görev süresi	2.6yrs

Son yönetim güncellemeleri

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Nov 15

Recent updates

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Nov 15

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Nov 17

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Nov 16

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

Feb 08

CEO

Peter Sargent (46 yo)

1.2yrs

Görev süresi

Dr. Peter Joseph Sargent is Chief Operating Officer of Physiomics Plc from September 04, 2023 and serves as its Chief Executive Officer and Director from January 22, 2024. He joined Physiomics Plc in Septe...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Peter Sargent	CEO, COO & Director	1.2yrs	Veri yok	Veri yok
David Fell	Co-Founder & Member of Scientific Advisory Board	no data	UK£2.63k	Veri yok
Anthony Clayden	Head of Finance & Company Secretary	8.5yrs	Veri yok	Veri yok
Hayley Close	Head of Business Development	3.3yrs	Veri yok	Veri yok
Venkata Putcha	Head of Biostatistics	1.1yrs	Veri yok	Veri yok
Mark Middleton	Consultant & Member of Scientific Advisory Board	9.3yrs	Veri yok	Veri yok
Robert Jackson	Consultant & Member of Scientific Advisory Board	no data	Veri yok	Veri yok

3.3yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: PYC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Peter Sargent	CEO, COO & Director	less than a year	Veri yok	Veri yok
David Fell	Co-Founder & Member of Scientific Advisory Board	no data	UK£2.63k	Veri yok
Mark Middleton	Consultant & Member of Scientific Advisory Board	9.3yrs	Veri yok	Veri yok
Robert Jackson	Consultant & Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Shalabh Kumar	Independent Non-Executive Director	2.2yrs	UK£23.67k	Veri yok
Timothy Corn	Independent Non-Executive Director	2.6yrs	UK£20.00k	Veri yok
James Millen	Non-Executive Chairman	8.5yrs	UK£138.61k	0.93% £ 12.2k

2.6yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PYC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.6 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Physiomics Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Physiomics Plc, Annual General Meeting, Nov 19, 2024

Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc

Less than half of directors are independent

Physiomics plc Announces Chief Executive Officer Changes

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Physiomics Plc, Annual General Meeting, Nov 21, 2023

Recent updates

Physiomics Plc, Annual General Meeting, Nov 19, 2024

Full year 2024 earnings: Revenues miss analyst expectations

New minor risk - Financial data availability

New major risk - Shareholder dilution

Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc

Physiomics Plc Increases Revenue Expectation for the Year 2025

First half 2024 earnings released: UK£0.002 loss per share (vs UK£0.002 loss in 1H 2023)

Physiomics Plc to Report First Half, 2024 Results on Mar 07, 2024

New minor risk - Shareholder dilution

Less than half of directors are independent

Physiomics plc Announces Chief Executive Officer Changes

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Physiomics Plc, Annual General Meeting, Nov 21, 2023

Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

New minor risk - Financial data availability

New minor risk - Financial data availability

Physiomics plc Appoints Dr. Peter Sargent as Chief Operating Officer

New minor risk - Shareholder dilution

First half 2023 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in 1H 2022)

Physiomics plc Announces Change of Job Title of Dr. Christophe Chassagnole from Chief Operating Officer to Chief Scientific Officer

Physiomics Plc Announces Successful Completion of its PARTNER Study

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Physiomics Plc, Annual General Meeting, Nov 22, 2022

Third quarter 2022 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 3Q 2021)

Physiomics Plc to Report Fiscal Year 2022 Results on Sep 29, 2022

Physiomics Plc Appoints Shalabh Kumar as Independent Non-Executive Director

Less than half of directors are independent

Physiomics plc Announces Board Changes, Effective April 1, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Physiomics Plc to Report First Half, 2022 Results on Mar 07, 2022

Physiomics plc Announces Board Changes

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Full year 2021 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in FY 2020)

Physiomics plc Announces Earnings Guidance for the Year Ending June 30, 2021

First half 2021 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 1H 2020)

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

TRHC’s DoseMeRx Partners with Physiomics to Provide Precision Dosing for Oncology Medications

Physiomics Plc Announces Approval of NIHR-funded PARTNER Study

Full year earnings released - UK£0.00087 loss per share

Annual earnings released: Earnings beat expectations, revenue disappoints

Physiomics plc Receives Award from Bicycle Therapeutics plc and Merck KGaA to Further Contracts of Undisclosed Value for Projects

Full year earnings released - UK£0.00087 loss per share

Physiomics Plc to Report Fiscal Year 2020 Results on Sep 30, 2020

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş